A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.

MLA

Rajput, Vishal K., et al. “A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-Glycan Interactions in a Pulmonary Fibrosis Model.” Journal of Medicinal Chemistry, vol. 59, no. 17, Sept. 2016, pp. 8141–47. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.6b00957.

APA

Rajput, V. K., MacKinnon, A., Mandal, S., Collins, P., Blanchard, H., Leffler, H., Sethi, T., Schambye, H., Mukhopadhyay, B., & Nilsson, U. J. (2016). A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model. Journal of Medicinal Chemistry, 59(17), 8141–8147. https://doi.org/10.1021/acs.jmedchem.6b00957

Chicago

Rajput, Vishal K, Alison MacKinnon, Santanu Mandal, Patrick Collins, Helen Blanchard, Hakon Leffler, Tariq Sethi, Hans Schambye, Balaram Mukhopadhyay, and Ulf J Nilsson. 2016. “A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-Glycan Interactions in a Pulmonary Fibrosis Model.” Journal of Medicinal Chemistry 59 (17): 8141–47. doi:10.1021/acs.jmedchem.6b00957.